CRISM Therapeutics Corporation
-
Ticker
CRTX
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Road Town, British Virgin Islands
CRISM Therapeutics Corporation is a UK-based pharmaceutical company which has developed an innovative drug delivery technology, ChemoSeed, to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy. ChemoSeed will initially be used to treat glioblastoma, a brain tumour with no satisfactory treatment.
REPORT RATINGS
4.8 / 5.0 (84)
CRISM Therapeutics Corporation reports have an aggregate usefulness score of 4.8 based on 84 reviews.
CRISM Therapeutics Corporation
Most Recent Annual Report
MOST RECENT
2023 Annual Report
Older/Archived Annual Reports